Activación del polisacárido capsular de Streptococcus pneumoniae serotipo 23F para la obtención de vacunas conjugadas

2017 
Nowadays conjugate vaccines are a major milestone in the development of drugs against infectious diseases. These vaccines drastically reduce mortality and morbidity from different diseases caused by bacteria in children; but also impact on non-vaccinated population. Conjugate vaccines are based on a covalent bond between a polysaccharide and a carrier protein for which there are different chemical procedures. All conjugate procedures require the presence of additional reactive groups that often are generated in both macromolecules. This work focus on the study of the fragmentation reaction and peryodic oxidation on the capsular polysaccharide serotype 23F Streptococcus pneumoniae for use as a vaccine antigen. It was possible to establish the fragmentation reaction of the polysaccharide by hydrolysis with acetic and trifluoroacetic acid. Directly proportional ratio was found between numbers of moles of sodium periodate and temperature on the oxidation reactions. In addition the glycerol-phosphate substituent was found as important motif to preserve the antigenicity. The procedure allows immunogenic conjugate from capsular polysaccharide serotype 23F of Streptococcus pneumoniae in rabbit models.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    17
    References
    1
    Citations
    NaN
    KQI
    []